GMED GMED グロ―バス・メディカル

 GMEDのチャート


 GMEDの企業情報

symbol GMED
会社名 Globus Medical Inc (GMED グロ―バス・メディカル)
分野(sector)   
産業(industry)   
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 グロバス・メディカル(Globus Medical Inc.)は医療機器会社である。同社は筋骨格系障害患者向け製品を開発する。同社は脊椎疾患患者の治療を中心とする。同社の製品は革新的融合技術と破壊的技術を含む。革新的融合技術製品には脊椎全体の脊髄障害を治療するための融合製品が含まれ、外科的アプローチで使用できる。破壊的技術製品は外科的処置と脊髄障害の治療を可能にすることによって、脊髄障害の治療における変化を表す。QUARTEXは、Occipito-Cervico-Thoracic(OCT)安定化システムである。QUARTEXは低トルクを可能にするネジロックキャップを有する。同社のパイプライン・ディスラプティブ・テクノロジー製品ポートフォリオには最小侵襲外科(MIS)技術を可能にする製品が含まれる。  グロ―バス・メディカルは米国の医療機器メ―カ―。脊椎疾患治療を中心に製品を開発、製造、販売する。同社の製品は革新的融合技術製品と破壊的技術製品の2分野に分類され、製品には脊椎固定機器「カリバ―」、頚椎固定用プレ―ト「アシュア」、椎弓形成術用器具「キャノピ―」などがある。  Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders.
本社所在地 610 930-1800
代表者氏名 David C. Paul
代表者役職名 Executive Chairman of the Board
電話番号 +1 610-930-1800
設立年月日 37681
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 1800人
url www.globusmedical.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 218.51200
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 4874.46700
売上高 売上高(百万ドル) 712.96900
企業価値(EV) 企業価値(EV)(百万ドル) 4534.78300
当期純利益 当期純利益(百万ドル) 156.47300
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Globus Medical Inc revenues increased 12% to $713M. Net income before extraordinary items increased 32% to $156.5M. Revenues reflect United States segment increase of 12% to $593.9M International segment increase of 12% to $119.1M. Net income benefited from Interest income net increase from $6.6M to $13.3M (income) Other income/(loss) increase from $571K to $5.6M (income).

 GMEDのテクニカル分析


 GMEDのニュース

   The Global Joint Reconstruction Devices Market is Anticipated to Surpass USD 27 Million with a CAGR of 6.05% by 2026, Assesses DelveInsight  2022/04/26 17:00:00 Benzinga
New York, USA, April 26, 2022 (GLOBE NEWSWIRE) -- The Global Joint Reconstruction Devices Market is Anticipated to Surpass USD 27 Million with a CAGR of 6.05% by 2026, Assesses DelveInsight The Joint Reconstruction Devices market is witnessing immense growth due to the factors such as the increasing prevalence of arthritis, and musculoskeletal ailments along with the rising number of orthopedic surgeries, among others. According to the latest report published by DelveInsight, " Joint Reconstruction Devices Market Insight , the global Joint Reconstruction Devices market is expected to witness significant growth owing to an increase in the prevalence of arthritis and musculoskeletal ailments. Furthermore, the rising number of orthopedic surgeries in the developed regions, the rising prevalence of bone degenerative diseases, gout, and the technological advancements offered by the Joint Reconstruction Devices is also a major factor contributing to the Joint Reconstruction Devices market growth.
   Why Globus Medical Stock Is Sinking Today  2022/04/22 14:57:57 The Motley Fool
The company''s CEO unexpectedly resigned.
   Futures Drop With Traders On Edge Over Hawkish Central Banks  2022/04/22 11:49:35 Zero Hedge
Futures Drop With Traders On Edge Over Hawkish Central Banks US equity futures extended their Thursday losses, and were slightly lower on Friday morning as investors fretted over the latest hawkish remarks from Jerome "Crash Stonks" Powell. Nasdaq 100 futs were down 0.1% by at 7:15a.m. EDT after the underlying gauge slumped 2% on Thursday after Powell outlined his most aggressive approach yet to taming inflation, potentially endorsing two or more half percentage-point interest-rate increases, which prompted the market to price in more than six 25bps rate hike by the end of July and 10 hikes by the end of 2022. Shorter-dated Treasury yields surged. The dollar rose to the highest level since July 2020 amid losses for the British pound with data showing the U.K.’s cost-of-living crisis is hampering consumer spending. The overnight weakness pushed both S&P 500 futures lower by about 0.2% after cash closed down 1.5% Thursday, although trade was muted and range-bound. The fears over rising rates have been particularly damaging for frothy growth and technology parts of the market amid concerns about the squeeze on their future earnings. “The problem for the equity market and particularly those rate sensitive long duration stocks is they are simply not valued appropriately for that new regime, ” said Roger Lee, head of U.K. equity strategy at Investec. “Investors have been so heavily concentrated in those ‘growth’ parts of the market that the unwind and repositioning as this new rate environment sinks in could take months, if not years.” “Equities are really torn between these two forces right now and the first one is that earnings are actually pretty good,” Anastasia Amoroso, chief investment strategist at iCapital Securities LLC, said on Bloomberg Television.
   Globus Medical Issues Softer Outlook For Q1, CEO Resigns  2022/04/22 11:47:07 Benzinga
Globus Medical Inc (NYSE: GMED ) announced the resignation of President and CEO Dave Demski after nearly 20 years with the company, with the last four and a half years as its CEO. The Board of Directors has named Daniel Scavilla as the company''s President and CEO, effective immediately. Dave will remain with … Full story available on Benzinga.com
   Globus Medical drops 14% on prelim Q1 sales figure below consensus, names new CEO  2022/04/21 20:29:25 Seeking Alpha
Globus Medical (GMED) President and CEO, Dave Demski resigns after nearly 20 years with the company, with the last four and a half years as its CEO.
   The Global Joint Reconstruction Devices Market is Anticipated to Surpass USD 27 Million with a CAGR of 6.05% by 2026, Assesses DelveInsight  2022/04/26 17:00:00 Benzinga
New York, USA, April 26, 2022 (GLOBE NEWSWIRE) -- The Global Joint Reconstruction Devices Market is Anticipated to Surpass USD 27 Million with a CAGR of 6.05% by 2026, Assesses DelveInsight The Joint Reconstruction Devices market is witnessing immense growth due to the factors such as the increasing prevalence of arthritis, and musculoskeletal ailments along with the rising number of orthopedic surgeries, among others. According to the latest report published by DelveInsight, " Joint Reconstruction Devices Market Insight , the global Joint Reconstruction Devices market is expected to witness significant growth owing to an increase in the prevalence of arthritis and musculoskeletal ailments. Furthermore, the rising number of orthopedic surgeries in the developed regions, the rising prevalence of bone degenerative diseases, gout, and the technological advancements offered by the Joint Reconstruction Devices is also a major factor contributing to the Joint Reconstruction Devices market growth.
   Why Globus Medical Stock Is Sinking Today  2022/04/22 14:57:57 The Motley Fool
The company''s CEO unexpectedly resigned.
   Futures Drop With Traders On Edge Over Hawkish Central Banks  2022/04/22 11:49:35 Zero Hedge
Futures Drop With Traders On Edge Over Hawkish Central Banks US equity futures extended their Thursday losses, and were slightly lower on Friday morning as investors fretted over the latest hawkish remarks from Jerome "Crash Stonks" Powell. Nasdaq 100 futs were down 0.1% by at 7:15a.m. EDT after the underlying gauge slumped 2% on Thursday after Powell outlined his most aggressive approach yet to taming inflation, potentially endorsing two or more half percentage-point interest-rate increases, which prompted the market to price in more than six 25bps rate hike by the end of July and 10 hikes by the end of 2022. Shorter-dated Treasury yields surged. The dollar rose to the highest level since July 2020 amid losses for the British pound with data showing the U.K.’s cost-of-living crisis is hampering consumer spending. The overnight weakness pushed both S&P 500 futures lower by about 0.2% after cash closed down 1.5% Thursday, although trade was muted and range-bound. The fears over rising rates have been particularly damaging for frothy growth and technology parts of the market amid concerns about the squeeze on their future earnings. “The problem for the equity market and particularly those rate sensitive long duration stocks is they are simply not valued appropriately for that new regime, ” said Roger Lee, head of U.K. equity strategy at Investec. “Investors have been so heavily concentrated in those ‘growth’ parts of the market that the unwind and repositioning as this new rate environment sinks in could take months, if not years.” “Equities are really torn between these two forces right now and the first one is that earnings are actually pretty good,” Anastasia Amoroso, chief investment strategist at iCapital Securities LLC, said on Bloomberg Television.
   Globus Medical Issues Softer Outlook For Q1, CEO Resigns  2022/04/22 11:47:07 Benzinga
Globus Medical Inc (NYSE: GMED ) announced the resignation of President and CEO Dave Demski after nearly 20 years with the company, with the last four and a half years as its CEO. The Board of Directors has named Daniel Scavilla as the company''s President and CEO, effective immediately. Dave will remain with … Full story available on Benzinga.com
   Globus Medical drops 14% on prelim Q1 sales figure below consensus, names new CEO  2022/04/21 20:29:25 Seeking Alpha
Globus Medical (GMED) President and CEO, Dave Demski resigns after nearly 20 years with the company, with the last four and a half years as its CEO.
   Globus Medical Inc. (GMED) Forecast: Revisiting The Past To Gain Insights For The Future  2022/04/09 17:00:00 Stocks Register
Globus Medical Inc. (NYSE:GMED) concluded the trading at $76.35 on Friday, April 08 with a rise of 0.53% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $75.95 and 5Y monthly beta was reading 1.09 with its price kept floating in the … Globus Medical Inc. (GMED) Forecast: Revisiting The Past To Gain Insights For The Future Read More »
   Orthopedic Implants Market | Increasing Incidences of Arthritis Worldwide Drive the Growth - MDC Research  2022/04/07 10:33:10 Benzinga
Pune, April 07, 2022 (GLOBE NEWSWIRE) -- Orthopedic implants are medical devices which are used to support or replace damaged joints or bones. These implants are fabricated using several materials, namely titanium, stainless steel, and other plastic materials. These implants play a vital role in addressing several musculoskeletal conditions, by restoring mobility and reducing pain. Moreover, these implants further assists in treating deformities, restore normal skeletal function and stabilizing body posture among others. Orthopedic Implants Market by Regions The global market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of orthopedic implants, followed by Europe and Asia Pacific. North America will continue to dominate the global market in the forecast period owing to factors such as increasing incidences of musculoskeletal disorders, growing geriatric population and availability of advanced implant products. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, Korea, Japan and India.
   Where Globus Medical Stands With Analysts  2022/03/28 20:24:02 Benzinga
Analysts have provided the following ratings for Globus Medical (NYSE: GMED ) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 2 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 1 1 0 0 3M Ago 0 1 1 0 0 In the last 3 months, 6 analysts have offered 12-month price targets for Globus Medical. The company has an average price target of $81.83 with a high of $91.00 and a low of $74.00. Below is a summary of how these 6 analysts rated Globus Medical over the past 3 months. The greater the number of bullish ratings, the more … Full story available on Benzinga.com
   Globus Medical initiated at Wells Fargo at overweight on market growth (NYSE:GMED)  2022/03/28 14:07:55 Seeking Alpha
Wells Fargo initiated medical device company Globus Medical (GMED) with an overweight rating based on the companys market growth and share gains, as well as EBITDA margin.
   HAPPE SPINE ANNOUNCES NEW ADDITIONS TO BOARD OF DIRECTORS  2022/03/28 11:42:00 Kwhen Finance

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 GMED グロ―バス・メディカル GMED )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)